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Background: To investigate the potential association between oral health and cognitive function, a pilot study was
conducted to evaluate high throughput DNA sequencing of the V3 region of the 16S ribosomal RNA gene for
determining the relative abundance of bacterial taxa in subgingival plaque from older adults with or without
dementia.
Methods: Subgingival plaque samples were obtained from ten individuals at least 70 years old who participated in
a study to assess oral health and cognitive function. DNA was isolated from the samples and a gene segment from
the V3 portion of the 16S bacterial ribosomal RNA gene was amplified and sequenced using an Illumina HiSeq1000
DNA sequencer. Bacterial populations found in the subgingival plaque were identified and assessed with respect to
the cognitive status and oral health of the participants who provided the samples.
Results: More than two million high quality DNA sequences were obtained from each sample. Individuals differed
greatly in the mix of phylotypes, but different sites from different subgingival depths in the same subject were
usually similar. No consistent differences were observed in this small sample between subjects separated by levels
of oral health, sex, or age; however a consistently higher level of Fusobacteriaceae and a generally lower level of
Prevotellaceae was seen in subjects without dementia, although the difference did not reach statistical significance,
possibly because of the small sample size.
Conclusions: The results from this pilot study provide suggestive evidence that alterations in the subgingival
microbiome are associated with changes in cognitive function, and provide support for an expanded analysis of the
role of the oral microbiome in dementia.
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In addition to the hypothesized link between oral health
and chronic systemic diseases, such as cardiovascular
disease, stroke, and diabetes, there now appears to be an
association between oral health and neurodegenerative
diseases, ranging from mild to moderate loss of cognitive
function to Alzheimer’s Disease (AD) [1]. Poorer cogni-
tive performance and tooth loss have been linked* Correspondence: ccuff@hsc.wvu.edu
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reproduction in any medium, provided the orepidemiologically in both retrospective and prospective
studies [2-7], and tooth loss has been associated with an
increased risk of both dementia and cognitive decline
[8]. Indeed, increasing tooth loss over time is associated
with increased likelihood of low cognitive scores [2]. Be-
yond epidemiological associations, independent lines of
experimental evidence support the hypothesis that bac-
teria associated with diseases of the oral cavity contrib-
ute to neurodegeneration. Oral bacteria and bacteria
closely related to those found in the oral cavity have
been found at a higher frequency post mortem in the
brains of patients with AD than in those of patients who
did not have AD [9,10]. In addition, the Third Nationalral Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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III) provided evidence that gingival bleeding and loss of
periodontal attachment were associated with lower cog-
nitive function [11]. Furthermore, subjects with high
levels of antibody against the periodontal pathogen Por-
phyromonas gingivalis had significantly greater impaired
verbal memory and subtraction test performance, and
this finding remained robust when adjusting for poten-
tial sociodemographic and vascular confounders [12].
Levels of immunoglobulin G (IgG) antibodies and serum
tumor necrosis factor levels have been found to discrim-
inate between normal subjects and AD patients [7], and
recently Sparks Stein et al. [13] found that elevated anti-
body levels to periodontal disease bacteria were observed
in subjects years before cognitive impairment, suggesting
that periodontal disease could potentially contribute to
the risk of AD onset or progression.
If oral health is linked to neurodegeneration, it is
plausible that bacteria found in the oral cavity play a
causal role in establishing this link. The collection of
microorganisms in the oral cavity, the ‘oral microbiome’,
has been studied using a variety of molecular methods
that can identify both cultivatable and non-cultivatable
bacteria within various ecological niches in the oral cav-
ity [14,15]. Despite the evidence linking oral health and
cognitive function, there is a paucity of empirical data
that assess the oral microbiome in patients with cogni-
tive degeneration [16]. Microbiome analysis could be
used to determine whether the bacterial compositions of
the oral microbiome or ‘bacterial signatures’ could serve
as a predictive biomarker for increased risk of cognitive
impairment. It is also possible that preventive treatment
could target the makeup of the oral microbiome and the
efficacy of such treatment could be monitored with this
approach.
Recent advances in the availability and reduced costs of
high throughput DNA sequencing and bioinformatics
tools provide a broadly available and increasingly cost ef-
fective method to identify bacterial populations found in
polymicrobial biofilms associated with human tissue, in-
cluding the oral cavity [17-19]. The present study was
undertaken to develop a sampling and analysis pipeline
using next generation DNA sequencing technology that
could be used to characterize microbial populations in
subgingival plaque samples. Using an Illumina HiSeq1000
DNA sequencer and a sample preparation and analysis
pipeline that enabled multiple samples to be sequenced
within the same sequencing lane, we were able to gener-
ate and analyze economically more than one million bac-
terial DNA sequences from each of 15 subgingival plaque
samples. The participants were enrolled in a study that
assessed oral health and cognitive function among adults
at least 70 years old from West Virginia, some of whom
were from medically underserved communities [20].These sequences were analyzed using bioinformatics tools
available in the publicly accessable software package
Quantitative Insights into Microbial Ecology (QIIME)
[21], and sequence comparisons were made among parti-
cipants who were clinically assessed as normal or exhib-
ited alterations in cognitive function. The results provide
a road map for future efforts to use high throughput
DNA sequencing to characterize the oral microbiome in
the context of systemic disease, and provide preliminary
evidence that differences exist in the bacterial compos-
ition of subgingival plaque in patients with alterations in
cognitive function. In contrast to other approaches to
microbiome analysis, high throughput sequencing holds
out the promise of also being useful for metagenomic
analysis of the oral microbiome to identify potential viru-
lence factors that contribute to systemic disease.
Methods
Oral health screening, cognitive analysis, and sample
collection
All samples were collected under a protocol reviewed and
approved by the West Virginia University Institutional
Review Board. The criteria for study participants were age
70 years or older, resident of West Virginia, community-
living, and at least four natural teeth. Oral evaluations
were performed by calibrated researchers using guidelines
from the NHANES 1999 to 2000 [22]. A psychometrician
administered to the participants a battery of neuro-
psychological measures that assessed verbal and visual
memory, language, executive function, orientation, praxis,
and reading ability. Depression was assessed using the
Geriatric Depression Scale [23]. A proxy informant, usu-
ally a spouse or adult child, provided information about
the participant’s cognitive function, functional limitations,
medical history, and medications. All collected data were
reviewed by two study psychologists and diagnoses were
assigned within three cognitive categories: normal cogni-
tive function, cognitive impairment without dementia
(CIND), and dementia. The Diagnostic and Statistical
Manual of Mental Disorders, Fourth Edition, criteria were
used for the diagnosis of dementia [24]. CIND was
defined as mild cognitive or functional impairment
reported by the participant or informant that did not
meet the criteria for dementia, or performance on neuro-
psychological measures that was both below expectations
based on reading ability and educational and occupational
history, and at least 1.5 standard deviations below pub-
lished norms on any test within a cognitive domain (for
example, memory, orientation, language, executive func-
tion, praxis). Diagnoses were anchored by these criteria,
but the final diagnoses were based on clinical judgment.
Similar assessment and diagnostic procedures have been
used and validated in multiple large epidemiological stud-
ies on cognitive impairment in later life [25,26].
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duals were sequenced for this report, four of which (N1,
N2, C2, C3) were obtained and partially analyzed during
an earlier phase of the study [16]. Eleven additional sub-
gingival plaque samples were obtained using sterile peri-
odontal curettes from pocket probing depths of 1 to
3 mm, 3 to 5 mm, or >5 mm. These samples were col-
lected into tubes containing Invitek SalivaGene DNA
stabilization buffer (STRATEC Molecular GmbH, Berlin,
Germany). In most cases, multiple plaque samples from
the same pocket probing depth in the same participant
were pooled into one tube for DNA extraction.
DNA extraction
DNA from the 11 new samples was purified using an
Invitek PSP SalivaGene DNA Kit. As part of the purifica-
tion procedure, 100 μg of lysozyme (Sigma-Aldrich, St.
Louis, MO, USA) was added to each tube, the mixture
incubated at 37°C for 10 minutes, and then processed
according to the manufacturer's recommendations.
PCR and fragment purification
PCR primers, conditions for amplification of sequences
in the V3 region of the 16S ribosomal RNA gene, and a
multiplexed DNA sequencing strategy were as described
in Bartram et al. [27] unless otherwise indicated. The V3
region varies in length by about 30 base pairs among dif-
ferent species of bacteria in the Greengenes database,
and the sequences obtained and analyzed in this study
showed a similar size variability. The amplicon ranges
from 296 to 327 base pairs, of which 160 base pairs is
the primer. High pressure liquid chromatography-
purified PCR primers were obtained from Integrated
DNA Technologies (Coralville, IA, USA). Purified DNA
was amplified using an AccuPrime PCR Kit (Invitrogen
Life Technologies, Grand Island, NY, USA) on an MJ Re-
search PTC-200 Thermal Cycler using the following
conditions: 95°C for 6 minutes denature; 95°C for 2 min-
utes, 50°C for 2 minutes, 72°C for 2 minutes 30 cycles;
72°C for 4 minutes extend. Each reaction contained
0.5 μl TAQ polymerase, 5 μl 10x buffer 1(600 mM Tris-
SO4 (pH 8.9), 180 mM (NH4)2SO4, 20 mM MgSO4,
2 mM dGTP, 2 mM dATP, 2 mM dTTP, 2 mM dCTP,
thermostable AccuPrime™ protein, 10% glycerol), 20 μM
forward primer, 20 μM reverse primer, and up to 60 ng
DNA in a total volume of 50 μl. PCR reactions were per-
formed in triplicate and reaction products were pooled
prior to purification. Because there was a low concentra-
tion of DNA in some of the samples, it was necessary to
perform 30 cycles of amplification to obtain sufficient
material to view on a gel. Pooled PCR products were
purified by electrophoresis through 2% agarose in Tris/
borate/EDTA gels and the bands corresponding to ap-
proximately 300 base pairs were excised and purifiedusing a QIAquick Gel Extraction Kit (Qiagen, Valencia,
CA, USA) according to the manufacturer's directions.
DNA sequencing
Indexed libraries were pooled so that 12 libraries were
sequenced in each lane of the flow cell. Eight pmols of
the pooled libraries were clustered onto an Illumina v2
sequencing flow cell using an Illumina cBOT. Libraries
were then sequenced in a 2 x 125 bp paired-end strategy
on an Illumina HiSeq1000, so that the forward and re-
verse reads could be assembled into a single contig.
Reads were converted from Illumina bcl format to fastq
format and separated into bins based on exact match to
the index using CASAVA 1.8.2 (Illumina, San Diego CA,
USA). An average of 6.7 million reads/sample passing
the filter was sequenced in each library.
DNA sequence processing
Sequence files were initially processed by removing
sequences corresponding to linkers and primers by auto-
mated batch processing using scripts written in-house.
In an effort to reduce artifacts generated by sequencing
errors, a strict quality filtering protocol was employed
that reduced the number of analyzed sequences to ap-
proximately 35% of the total number of sequences gen-
erated. Nevertheless, an average of more than two
million high quality reads was obtained from each sam-
ple. Quality filtering of DNA sequences was performed
using the following steps: 1) Sequences were first filtered
by the Illumina software to eliminate the poorest reads
(Q score ≥ 30) and imperfect primer matches. 2) The for-
ward and reverse sequences were matched to construct
a sequence that spanned the entire region between the
primers with a program written in-house. The original
Illumina sequences were all 125 bases in length, which is
where the run ended. The pairing strategy overlaid the
two 3’ ends starting with an overlap of 58 bases. The
overlap window was extended one base at a time to 89
bases until a perfect match was obtained in the overlap
region. Any pair of sequences that did not match at
100% identity in any of the size windows was discarded.
This step eliminated 56% of the sequences, which over-
whelmingly had the lowest quality scores. In general, the
sequence quality was better in the middle than at the
end, so this preferentially eliminated sequences with se-
quencing artifacts. 3) Paired sequences with a Phred
quality score of less than five were discarded. This
removed a few remaining low quality sequences, espe-
cially any that had low quality in the regions between
the primers and the overlap. 4) The sequences were
clustered by matching against the Greengenes database,
which is a curated collection of known bacterial 16S
sequences. Sequences that did not match any of the
known bacterial sequences with 97% identity were
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artifacts and represented approximately 5% of the total
remaining sequences. Matching at 97% identity meant
that any single base PCR artifacts would be combined
with the corresponding authentic sequence (since the re-
gion is about 100 bases long, up to three single base
changes will be ignored). 5) The resulting table of oper-
ational taxonomic units (OTUs) was filtered to remove
any sequences that appeared less than 150 times.
Finally, scripts written in-house in biopython were used
to convert the filtered Illumina data to the FASTA format
for analysis by QIIME for taxonomic assignment and
measurements of microbial diversity, but scripts to do
this are now part of QIIME. To process Illumina-
generated files in QIIME, the file headers were changed
to begin with ‘>sample_number’ where ‘sample’ is the
sample number and ‘number’ is the number of the se-
quence in the file. All of the sequences were then com-
bined into one file for analysis with QIIME. DNA
sequences generated and analyzed in this study can be
found at the National Center for Biotechnology Informa-
tion Sequence Read Archive, project number SRA057340.
QIIME
All QIIME analyses were performed on a virtual server
hosted by Amazon Web Services using an existing QIIME
image. The server had the following specification: QIIME
1.4.0 EBS East XLARGE (ami-438d5b2a). The following
QIIME scripts were used during analysis and default
parameters were used unless otherwise noted: 1) ‘pick_
reference_otus_through_otu_table.py’ matched sequences
at 97% sequence identity with OTUs associated with spe-
cific bacterial phylotypes in the Greengenes database
(4Feb2011); 2) ‘summarize_taxa_through_plots.py’ gener-
ated bar graphs of the relative abundance of different taxa
in each sample; 3) ‘alpha_rarefaction.py’ generated alpha
rarefication plots; 4) ‘pick_rep_set.py’, ‘align_seqs.py’,Table 1 Demographics and health status of study participant
Sample ID Cognitive
assessment
Age Sex Race PPD Nu
of
N1 Normal 77 m w 2 22
N2 Normal 77 f w 2 11
C1 CIND >90 m w 4 20
C2 CIND >90 f w 3 19
C3 CIND 74 f b 3 22
D1 Dementia 82 m w 4 07
D2 Dementia 78 f w 4 28
D3 Dementia 89 f w 4 14
D4 Dementia 70 m w 6 19
D5 Dementia >90 f w 2 10
aAs described in Methods; bNot done. b, black; CIND, cognitively impaired, without‘filter_alignment.py’, and ‘make_phylogeny.py’ were
chained to generate a phylogenetic tree of the OTUs; 5)
‘beta_diversity_through_plots.py’ (using the phylogenetic
tree and the weighted UniFrac option) generated a beta
diversity table and principle coordinate plots for the
inter-subject diversity; and 6) ‘otu_category_significance.
py’ generated analysis of variance (ANOVA) scores for all
OTUs versus various categories. This script calculated
raw, Bonferroni corrected, and false discovery rate cor-
rected probabilities.
Statistical analysis
Data analyses involved logistic regression as implemen-
ted in JMP/Pro Software (version 9.0.2) and random for-
ests as implemented in R Software [28].
Results
Demographics and health status of study participants
A total of 15 samples was obtained from 10 individual
participants. Participants ranged from 70 to 101 years
old, were a nearly even mix of men and women, and all
but one were self-identified as Caucasian. The number
of teeth retained by the participants ranged from 7 to
22. Additional features of their oral health examinations
are listed in Table 1.
Generation and filtering of DNA sequences
The Illumina sequencing run of the 15 DNA samples
generated a total of more than 100 million paired-end
DNA sequencing reads that met the initial quality filter-
ing criteria (Table 2). Approximately 44 million reads
could be aligned to produce a continuous sequence with
at least a 58 base overlap with 100% identity and of
these, more than 34 million DNA sequences passed all
quality filtering steps. These sequences were clustered
into OTUs matching the Greengenes database at 97%











0.18 0 0 1
0.82 0 5 4
0.00 1 0 0
NDb 1 4 3
0.73 0 0 0
0.14 0 0 0
1.00 1 0 0
0.71 2 13 3
1.00 3 36 0
0.00 1 2 0
dementia; f, female;,m, male; PPD, pocket probing depth (mm); w, white.
Table 2 Number of DNA sequences obtained during
processing
Processing step Total %
Initial Number of Sequences 101,081,862 100
Successful end pairing 44,142,704 44
PHRED score >5 36,213,577 36
OTUs identified and analyzed 34,655,555 34
Average sequences/sample 2,310,370 n.a.
n.a. not applicable; OTU operational taxonomic units.
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cies’, but the 97% identity rule typically applies across the
entire 16S rDNA sequence. If the V3 region is more or
less variable this rule may not apply accurately to a
shorter read length. An average of about 2.4 million
sequences was analyzed per DNA sample. Approxi-
mately 34% of the initial output of DNA sequences
could thus be assigned as high quality OTUs for analysis
using this sequencing and quality filtering pipeline.
OTUs containing fewer than 150 sequences were dis-
carded, resulting in identification of a total of 492 OTUs
in this study [See Additional file 1].
Population diversity in samples
Alpha diversity is the amount of population diversity
within a given sample. Alpha diversity was measured as
the number of phylotypes observed versus number of
sequences analyzed. Once each sequence was assigned
to an OTU, QIIME was used to assess the alpha diver-
sity of each subject and generate diversification plots
(Figure 1). The number of OTUs identified in subgingi-
val plaque samples ranged from 182 (CIND2) to 385
(Dementia 4). Population diversity essentially plateaued






























Figure 1 Alpha rarefaction plot demonstrating phylotype
diversity in subgingival plaque samples. Shown are the numbers
of different Operational Taxonomic Units (OTUs) as a function of the
numbers of sequences analyzed and generated with QIIME. OTUs
that occur less than 150 times/sample are not included. C,
cognitively impaired, not dementia; D, dementia; N, normal.this result was consistent across participants, irrespective
of the final diversity. Using the QIIME script otu_
category_significance.py to run ANOVA, the amount of
diversity among participants was not linked to the
method of DNA isolation, mental status, age, race, or
parameters of oral health listed in Table 1 (data not
shown). Although the population diversity varied among
participants, multiple samples from individual partici-
pants yielded similar curves when analyzed separately.
This characteristic is illustrated by the small error bars
in Figure 1, where results from separate samples taken
from different probing depths from some individuals
were combined and averaged.
Taxonomic assignments
Taxonomic assignments for DNA sequences from each
sample were made and analyzed at the phylum, class,
order, family, and genus levels. Because of the relatively
short region sequenced, assignments at the species level
were not robust. Results are shown for analysis of sam-
ples at the phylum and family levels for each participant
and for multiple probing depth sites where available. In
general, most of the identified bacteria were distributed
among the phyla Fusobacteria, Bacteroidetes, Firmi-
cutes, TM7, Actinobacteria, and Proteobacteria with less
than 1% contribution of bacteria from any other phyla
(Figure 2). There appeared to be a higher proportion of
Fusobacteria-specific sequences in the samples from par-
ticipants who did not have dementia compared to those
who did. Additionally, at the phylum level the proportion
of sequences identified as members of the Bacteroidetes
phylum seemed to be slightly elevated in the samples
from subjects with dementia. These potential relation-
ships were explored in more detail at lower taxonomic
levels. Sixty-eight different families were identified during
taxonomic assignment (Figure 2) and the large inter-
person variation in bacterial populations became evident.
Nevertheless, the most striking observation was that in a
comparison of samples in the non-dementia versus the
dementia groups, the non-dementia samples had a higher
proportion of sequences identified as from the family
Fusobacteriaceae (primarily genera Fusobacterium and
Leptotrichia) and a lower proportion of sequences from
Prevotellaceae (almost entirely Prevotella).
The two most common families varied in the diversity
of detected phylotypes. Sixty-nine phylotypes of Prevo-
tella and one rare phylotype not assigned to a genus
were seen in the Prevotellaceae. There was substantial
diversity in the phylotypes of Prevotella (Figure 3), as
has been recently reported in ethnically diverse popula-
tions including those of Aboriginal descent in Australia
[29] and in a population from the Netherlands [19]. In
contrast, only 17 phylotypes of Fusobacteriaceae were


























Figure 2 Taxonomic assignments found in subgingival plaque clustered by cognitive status. Counts for each OTU that was identified
more than 150 times/sample were included in this analysis. The total height of the bar represents 100% of the assigned sequences after quality
filtering, and the size of the colored regions represents proportional contributions of each phylotype shown. For clarity, only major families (>3%)
are listed in the color key. OTU, Operational Taxonomic Units.
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of Fusobacterium, although this was the most common
genus in the entire data set.
Subroutines in QIIME were used to compute the Uni-
Frac weighted beta diversity distance matrix among sam-
ples. Beta diversity is the measure of differences between
samples in the abundance of phylotypes. Weighted Uni-
Frac takes into account the phylogenetic distances be-
tween the OTUs, so that it captures differences not only
at the level of individual phylotypes but also differences
at higher taxonomic levels. The first two principal coor-
dinates are plotted in Figure 4. The normal and CIND
subjects tend to cluster in the top left of the graph and
the subjects with dementia tend to be in the upper and
lower right half of the graph. There is no obvious separ-
ation of normal from CIND. The first principalcoordinate separates all but one of the normal/CIND
subjects from the participants with dementia and the
second principal coordinate provides some additional
separation. The observed clustering in the non-dementia
samples was due to differences in Fusobacteriaceae and
Prevotellaceae. When the analysis was conducted with
only Fusobacteriaceae and Prevotellaceae, the first co-
ordinate completely separated the participants with de-
mentia from the others. When all Fusobacteriaceae and
Prevotellaceae were removed and the analyses repeated,
there was no clustering of the non-dementia samples
(Figure 4). Dementia versus non-dementia was the only
variable that produced clustering on the principal coor-
dinates plot. No clustering was evident for gingivitis
score, age, sex, or number of teeth (data not shown). A
variety of tests were used to determine whether these
*Figure 3 High number of distinct OTUs assigned to Prevotellaceae from both dementia and non-dementia samples. The number of
distinct OTUs that are identified in four families that represent 2/3 of the total sequences were averaged for all samples and shown. Error bars
represent standard error. Asterisk represents statistically significant difference by analysis of variance followed by Tukey’s multiple comparison test
(P< 0.05). OTU, Operational Taxonomic Units.
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tic regression analysis indicated that the levels of Fuso-
bacterium and Prevotella were significantly different
(P <0.0018 and P <0.0049, respectively) between non-
dementia and dementia. However, random forest analysis,
a somewhat more robust test of statistical significance
indicated that the observed differences did not reach stat-
istical significance.
Samples from multiple probing depths were obtained










































































Figure 4 Clustering of bacterial taxa by cognitive function. Weighted
communities and a scatterplot was generated from the matrix of distances
the values of all samples from one participant analyzed collectively. In the
in the analysis. In the middle panel, the OTU table is further edited to remo
the right hand panel, only OTUs that were identified as Fusobacteriaceae o
square) cognitively impaired without dementia, and (purple triangle) demepaired samples at the phylum and genus levels are
shown in Figure 5. In samples from four of the five par-
ticipants, subgingival plaque harbored similar distribu-
tions of genera irrespective of probing depth, although
the percentages of minor genera differed substantially
among participants. However, for the two samples from
Dementia 3, the samples from the shallower probing
depth of 3 to 5 mm contained high levels of lactobacilli
and streptococci, whereas the sample from >5 mm con-


































PC1 Percent Variation Explained 80.9%
Only
Fusobacteriaceae and Prevotellaceae 




d, Not Dementia          Dementia
UniFrac was used to generate a matrix of pairwise distances between
using Principal Coordinate Analysis in QIIME. Each symbol represents
left hand panel all OTUs that occur more than 150 times are included
ve any OTUs assigned to the Fusobacteriaceae or Prevotellaceae. In
r Prevotellaceae were analyzed. (green circle) cognitively normal, (red





















Figure 5 Comparison of phylotypes found at various pocket probing depths (PPDs). Sample identifications as in Table 1 and PPDs are
listed at the base of each bar. For PPD: 1 = 1 to 3 mm, 3 = 3 to 5 mm 5 => 5 mm. Results show at the phylum and genus levels. DNA samples
obtained from various PPDs were sequenced and analyzed separately. The total height of the bar represents 100% of the assigned sequences
after quality filtering, and the size of the colored regions represents proportional contributions of each phylotype shown. For clarity, only major
genera (>3%) are listed in the color key.
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The two purposes of this study were to develop a sample
preparation and analysis pipeline to assess the oral
microbiome using high throughput DNA sequencing,
and to expand an ongoing study on the relationship be-
tween oral health and cognitive function in older West
Virginians.The major advantage of the Illumina platform is its
capacity to generate millions of reads from each sample.
Because of the relatively short read lengths, care must be
used in choosing an appropriate region of the 16S RNA
gene for analysis using the Illumina platform. The V3 re-
gion was selected because the primers used are the same
as those used for older methods of bacterial community
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Illumina-based analysis of microbial communities from
environmental samples [27]. The region amplified in this
study is longer (170 to 190 bases) than the V6 region
(105 to 120 bases) [30] or the V5 region (approximately
82 bases) [18] sequenced in other studies. Using the
PCR primers described in Bartram et al. [27] it was pos-
sible to run up to 12 samples per sequencing lane in this
study, thereby substantially reducing the cost of the ana-
lysis. However, a challenge to using this system for
microbiome analysis is the relatively short read lengths
that are typically generated in a run (approximately
125 bp) and the lower quality of many of these reads.
These disadvantages are obviated by using a paired-end
sequencing approach, and successful microbiome ana-
lyses of various environmental niches [27] including the
oral cavity [18,31] have been documented. Furthermore,
recent additions to the QIIME program have stream-
lined analysis of Illumina-generated data. We used the
Greengenes database to identify the taxa corresponding
to our sequences. About 5% of our sequences were not
found in Greengenes; we believe that most of these are
artifacts, but it is possible that a small number of rare
OTUs could have been excluded, which limits the utility
of this approach for identifying very rare phylotypes with
a high level of confidence. Nevertheless, we successfully
obtained millions of sequences from each sample, yield-
ing profound details of the structure of the microbiome
in subgingival plaque.
Although the main goal of this pilot study was to work
out methods for obtaining high quality data and per-
forming subsequent analysis using validated, universally
available software and databases, two interesting obser-
vations were made during the phylogenetic analysis of
the data. First, a very high level of Fusobacteria was
found, particularly in the samples from normal and
CIND participants. Fusobacteria are well-studied anae-
robes that have been found with great frequency in the
oral cavity using culture-independent analyses [32-35],
and members of the genus Fusobacterium were previ-
ously found to be among the most commonly identified
species in the oral cavities of elderly patients [34,35],
particularly in association with root caries [35]. A second
novel observation was that the levels of Fusobacteriaceae
were lower, and that levels of Prevotellaceae were higher
in samples from subjects with dementia compared to
subjects without dementia. We had hundreds of taxa in
our results, so by chance some of them would likely ap-
pear to be correlated with dementia. However, Prevotel-
laceae and Fusobacteriaceae are the two most abundant
families of bacteria, and antibody levels to individual
species in those families have been shown to increase to
higher levels in people who develop dementia than in
those who do not [13].There are four possible explanations for the correla-
tions between dementia and components of the micro-
biome: 1) the correlations are spurious due to the small
sample size; 2) dementia affects the microbiome; 3) the
microbiome affects dementia; and 4) a third variable
affects both.
First, we acknowledge that the sample size is small and
that many more subjects need to be evaluated to obtain a
robust result. Whether a larger sample size will confirm
these preliminary observations is an open question.
Second, it might seem self-evident that individuals
with dementia have poor oral hygiene resulting from
changes in diet or oral hygiene behavior, and therefore
worse oral health than individuals without dementia. As
expected, the participants with dementia in this study
had on average, slightly more gingivitis, fewer teeth,
more caries, and much higher plaque indices. However,
while this is true on average, it was not always the case
on an individual basis. Participant Normal 2 had poor
oral health while participants Dementia 1 and Dementia
5 had relatively good oral health, albeit with fewer teeth.
Participant Dementia 2 had the highest number of teeth
of all those in the study. If dementia causes poor oral
health, which in turn causes the changes in the micro-
biome, then the correlations between the directly related
parameters (cognition and oral health, or oral health and
the microbiome) should be higher than the correlation
between the indirectly related parameters (cognition and
the microbiome). Since we found the opposite, the data
do not support the hypothesis that the observed differ-
ences are merely secondary effects of poor oral hygiene
in subjects with dementia.
We found more Prevotella on average in the samples
from participants with dementia than in the samples
from participants without dementia. However, the differ-
ence was not large and the statistical significance of that
finding was dependent on the statistical test used to
analyze the data. The number of Prevotellaceae phylo-
types was high in both groups of samples, supporting
many previous studies that showed diversity in Prevotel-
laceae phylotypes/species in the oral cavity [36]. In
addition, there was a slight but statistically significant in-
crease in the number of distinct OTUs in the dementia
samples compared to the non-dementia samples, raising
the question of whether there are phylotypes in the Pre-
votellaceae that contribute to dementia. At the species
and strain levels there are examples of specific genes
that could potentially contribute to virulence within the
Prevotellaceae family including genes that encode fim-
brial adhesins, phospholipases, host-resistance factors,
adenine-specific DNA-methyltransferase and 8-amino-7-
oxononanoate synthase [36,37]. Species-specific inser-
tion sequences have also been identified [37], but
whether these or other genes are disproportionately
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awaits metagenomic analyses. There were no other pre-
dominant phylotypes found in higher levels in partici-
pants with dementia compared to non-dementia, arguing
against the idea that the presence of certain bacteria pro-
motes dementia. However, the fact that higher levels of
Fusobacteriaceae were found in all samples from partici-
pants without dementia suggests an alternate explanation,
that perhaps certain oral bacteria provide protection
against dementia, possibly by filling environmental niches
that could be populated by more inflammatory microor-
ganisms, by actively suppressing local or systemic inflam-
matory responses, or by producing biomolecules that are
neuroprotective.
The final possibility is that both dementia and the
microbiome are affected by a third variable. There is a
strong genetic link to some forms of dementia, including
the presence of the APOE-e4 variant of the Apolipopro-
tein E gene [38]. It is possible that the presence or ab-
sence of specific taxa could be due to genetic factors in
the subject such as host immune responses, expression
of adhesion molecules on host tissues that affect bacter-
ial adherence, or other undefined factors. The relation-
ship between human genotype and the oral microbiome
needs to be studied carefully.
Sparks Stein et al. [13] found elevated levels of anti-
bodies to Prevotella intermedia and Fusobacterium nucle-
atum in the blood of subjects who later developed AD.
These investigators also found that subjects with Mild
Cognitive Impairment (MCI), unlike AD subjects, had no
differences in P. intermedia and F. nucleatum compared
to normal subjects, but had reduced levels of antibodies
to several other oral bacteria. Similarly, we found that our
normal and CIND subjects did not separate based on
their microbiome beta diversity and, in particular, that
their Prevotellaceae and Fusobacteriaceae were similar.
We hypothesize that our results can be reconciled with
those of Sparks Stein et al. by predicting that subjects
who will develop dementia have a leakier sub-gingival
compartment resulting in increased interaction between
the microbiome and the immune system, leading to
higher antibody levels to the most prevalent bacteria:
Fusobacterium and Prevotella. Compared to Prevotella,
Fusobacteria are much less genetically diverse at the 16S
gene, so they might be more sensitive to elevated serum
antibody levels because of less diversity of surface pro-
teins that could serve as targets for antibodies. Thus, later
in life one might predict that higher levels of antibody
might reduce levels of Fusobacteria yet fail to be as effect-
ive against genetically diverse Prevotella. Alternatively, it
is possible that the difference in findings for Fusobacteria-
ceae might be because Sparks Stein et al. were using anti-
bodies that would differentiate strains on the basis of
surface proteins while we used 16S ribosomal sequences.In summary, our results demonstrate, via high through-
put DNA sequencing, that substantial inter-person vari-
ability exists in the oral microbiome of subgingival
plaque. There appears to be a consistent difference in the
levels of Fusobacteriaceae, and perhaps Prevotellaceae, in
samples from patients who do or do not have dementia,
which should be studied in more detail.
Conclusions
We have shown that high throughput DNA sequencing
is an effective and inexpensive method for analyzing the
microbiome of oral subgingival plaque from individual
subjects. It is sensitive enough to provide a measure of
the bacteria from a single sampling site. Substantial
inter-person variability exists in the sub-gingival plaque
microbiome, while there is generally little variation at
depths ranging from 1 to 5 mm in an individual subject's
mouth. There appears to be a consistent difference in
the levels of Fusobacteriaceae, and perhaps Prevotella, in
samples from patients who do or do not have dementia,
which should be studied in more detail.
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at least 150 times in the analysis.
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